2008 Press releases

Displaying 1 - 10 of 17

8 December 2008
Positive ELACYT Phase II Results - Data presented at ASH

Clavis Pharma ASA (OSE: CLAVIS) announces positive interim clinical phase II results for ELACYT single agent therapy in patients with late stage acute myeloid leukaemia (AML).

23 October 2008
Third Quarter Report 2008

"Three products in clinical development" - Clavis Pharma ASA (OSE: CLAVIS) announced today the results for the third quarter 2008 ...